The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The FLARE score, circulating neutrophils, and association with COVID-19 outcomes in patients with solid tumors.
 
Elia Seguí
Research Funding - Amgen
 
Edouard Auclin
Consulting or Advisory Role - Amgen Astellas BioPharma; Genzyme; Sanofi Aventis GmbH
 
Juan Manuel Torres
No Relationships to Disclose
 
David Casadevall
Employment - Savana
 
Juan Aguilar-Company
No Relationships to Disclose
 
Marta Rodríguez
Speakers' Bureau - ROVI
 
Nicolas Epaillard
No Relationships to Disclose
 
Javier Gavira
Speakers' Bureau - LEO Pharma
Travel, Accommodations, Expenses - Lilly
 
Jose Carlos Tapia
Travel, Accommodations, Expenses - Merck; Rovi
 
Marco Tagliamento
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Roche; Takeda
Other Relationship - Amgen; Novartis
 
Sara Pilotto
Honoraria - AstraZeneca; BMS
Consulting or Advisory Role - Amgen; Merck
Speakers' Bureau - Amgen; AstraZeneca; BMS; Lilly; Merck; Novartis; Roche
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; BMS; Roche
 
Rafael Lopez
Stock and Other Ownership Interests - Nasasbiotech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen; lilly; MSD; Roche; Rovi
Speakers' Bureau - BMS; Lilly; Novartis; Pfizer; PharmaMar; Roche; Rovi
Research Funding - Lilly (Inst); Merck (Inst); Roche (Inst)
Expert Testimony - Gilead Sciences
Travel, Accommodations, Expenses - Pfizer; Pfizer; Pierre Fabre; Roche; Tesaro
 
Xabier Mielgo
No Relationships to Disclose
 
Juan Bautista Blaquier
No Relationships to Disclose
 
María Bluthgen
No Relationships to Disclose
 
Jose Nicolas Minatta
Speakers' Bureau - AstraZeneca Japan; Pfizer/Astellas
 
Cristina Urbano
No Relationships to Disclose
 
Aleix Prat
Employment - Novartis (I)
Stock and Other Ownership Interests - Reveal Genomics
Honoraria - Amgen; Daiichi Sankyo; Guardant Health; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; NanoString Technologies (Inst); Novartis; Oncolytics; Pfizer; Puma Biotechnology; Roche
Research Funding - Incyte (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - HER2DX filing; METHODS FOR BREAST CANCER TREATMENT AND PREDICTION OF THERAPEUTIC RESPONSE (US 63/023785); PCT/EP2016/080056: HER2 AS A PREDICTOR OF RESPONSE TO DUAL HER2 BLOCKADE IN THE ABSENCE OF CYTOTOXIC THERAPY; WO/2018/096191. Chemoendocrine score (CES) Based on PAM50 for breast cancer with positive hormone receptors with an intermediate risk of recurrence
Travel, Accommodations, Expenses - Daiichi Sankyo
Other Relationship - Oncolytics; Peptomyc
 
Alexandru Vlagea
No Relationships to Disclose
 
Laura Mezquita
Consulting or Advisory Role - Roche; Roche; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Roche; Tecnofarma
Research Funding - Amgen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche